台康生技股份有限公司 News Releases

TaiCoo Biologics Q4 2025 Financials

TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million… · 2025-12-01

[EirGenix, Inc.] 2026 Q1 EPS -0.47 NTD

EirGenix reported Q1 2026 EPS of -0.47 NTD and a net loss of 142 million NTD. · 2026-03-01

TaiCoo Biologics Q4 2025 Financials

TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million… · 2025-12-01

[EirGenix, Inc.] 2026 Q1 EPS -0.47 NTD

EirGenix reported Q1 2026 EPS of -0.47 NTD and a net loss of 142 million NTD. · 2026-03-01